ABSTRACT -Background and Objectives: Every year, suicide accounts for approximately one million preventable deaths worldwide. Suicidal behavior is complex and multi-determined with risk factors identified in multiple domains including clinical, genetic, environmental, behavioral, neurophysiological, and neurocognitive. Modeling causal pathways that integrate these factors may assist in better identification of high-risk individuals would allow for effective preventive intervention.
Introduction
Suicide accounts for approximately one million deaths a year worldwide 1 , and has devastating personal, family, and socioeconomic consequences. In the USA, it is the eleventh leading cause of death for all ages, and in 2005 suicide accounted for approximately 32,000 deaths, 1.3% of all deaths in the U.S 2 . The US suicide rate in 2005 was 11/100,000, with a rate of 17.7/100,000 in males and 4.5/100,000 in females 2 . Although lower than the USA, suicide rates in Spain for the same period, were also high: 12.0/100,000 in males and 3.9/100,000 in females 1 . In the US, suicide is the fifth leading cause of years of potential life lost before the age of 65 2 . The impact of suicidal behavior is even greater than the death rates suggests, because it not only involves the older population, but also markedly affects adolescents and young adults. In 2007, 14.5% of U.S. high school students reported they had seriously considered suicide during the preceding year, and more than 6.9% reported they had actually attempted suicide one or more times during the same period 3 . For every suicide death in the 15 to 24 yearold age group, it is estimated that 100 to 200 attempts are made 4 .
Over 90% of those who die by suicide have a psychiatric illness, with 60% of all suicides occurring in the context of a mood disorder 5 . Suicide attempt rates are also elevated among individuals with psychiatric disorders, with reported rates of suicide attempt of 29% in Bipolar disorder, 16% in Major Depressive Disorder 6 , 16-29% in alcohol use disorders [7] [8] [9] [10] , and 23-30% in psychotic disorders 11, 12 , compared to 4.6% reported in general population surveys 13 . However, the majority of psychiatric patients do not attempt suicide, so a more specific explanation for suicidal behaviour must be sought.
Many factors have been associated with suicide attempt and suicide in studies of clinical populations, including abnormal serotonergic, noradrenergic system and HPA axis function, deficits in executive function, smoking, and higher aggression, impulsivity, hopelessness, and pessimism [14] [15] [16] .
There is no single causal factor for suicidal behavior. Rather, it has been proposed that suicidal behavior occurs in the context of an interaction between a diathesis for suicidal behavior and the occurrence of acute stressors 17 . The diathesis refers to an individual's predisposition to manifest suicidal behavior in response to a stressor, is considered trait based, and is independent of psychiatric condition 17 . The diathesis for suicidal behavior is hypothesized to comprise factors or traits from multiple domains including biological, genetic, cognitive, personality, behavioral, and clinical (see 18 for an overview). Stressors act as triggers or precipitants and relate to both the timing and probability of suicidal acts and are considered state-related 17 . Stressors may include a major depressive episode, acute substance intoxication, or personal stressors (familial, social, or financial). Thus, suicidal behavior is not simply a reaction to extreme stress, nor does it necessarily correlate with the severity of a stressor, but results instead from the interaction of the individual's diathesis or predisposition to engage in suicidal acts and the occurrence of a trigger 17 . Given the multiple contributory causal factors, both in the diathesis and stressor domains, an explanatory model for suicidal behavior must be able to integrate risk factors into a multidimensional model that includes clinical, biological, genetic, behavioral, personality, and psychosocial traits as well as stressors and delineate causal pathways leading to suicidal outcomes.
An Integrated Model of Suicidal Behavior
The endophenotype approach is particularly relevant to the study of complex multidetermined behaviors such as suicide and suicide attempt. An endophenotype is an intermediary phenotype in the etiologic pathway from genes to disease 19 , and represent more basic constructs, symptoms, or characteristics that are more amenable to quantification 19 . Beyond focusing on the casual pathways between genes and suicidal behavior, the concept of an intermediary phenotype can also be useful as an approach to tracing the etiological pathways from observed neurochemical, neuroendocrine, and neurophysiological dysfunction to suicidal outcomes via behavioral, clinical, and cognitive alterations. In figure 1 we outline a putative model of suicidal behavior which originates with genetic and environmental factors and then delineates clinical, biological, and other risk factors identified in the literature, that may function as endophenotypes. Developing such explanatory models is a crucial step not only for identifying areas which require further investigation, but also for improving assessment of risk for suicidal behavior and identifying targets for preventive intervention. We will first outline some putative clinical, biological, and neurocognitive endophenotypes and describe the relationship between them, and then examine genetic and environmental considerations.
Clinical Endophenotypes
Clinical traits repeatedly associated with suicide attempt and suicide death across psychiatric diagnostic groups include impulsivity, aggression, pessimism, and hopelessness (for a review see 20 ). However, they are not sufficient to explain suicidal behavior, and these constructs or traits themselves are often complex or may be too loosely defined. For example, there are many types of impulsivity, which may potentially result from different underlying neurobiological anomalies 21 . Moreover, clinical traits may be causally interrelated, for example both pessimism and aggression/impulsivity predict suicidal acts, but they also have an additive NEUROBIOLOGICAL UNDERPINNINGS OF SUICIDAL BEHAVIOUR: INTEGRATING DATA... 245 Figure 1 effect on suicide attempt risk 22 . Addressing this complexity may require defining more precise constructs, and contextualizing traits in terms of related biological, genetic, and other domains of risk, so that a more finegrained assessment of the relevance of such traits to suicidal behaviors is possible.
Neurochemical Endophenotypes
Biological studies have examined the role of the serotonergic, noradrenergic, and dopaminergic systems in suicidal behavior, as well at the HPA axis stress response system.
Serotonergic system
The most consistent finding in suicidal individuals is dysfunction in the serotonergic system 16 . In suicide, altered serotonergic function has been evidenced in studies of the serotonin metabolite 5-hydroxyindoleacetic acid in cerebrospinal fluid (CSF 5HIAA), and of serotonin receptors and transporters in postmortem brain [23] [24] [25] [26] . In a metaanalysis of prospective studies, individuals with below median levels of CSF 5-HIAA were 4.5 times more likely to die by suicide than those in the above median group 27 . Lower concentration of CSF 5-HIAA has also been reported particularly in individuals who use violent methods to suicide or make higher lethality non-fatal attempts [28] [29] [30] [31] . Postmortem studies of the brain in individuals who have died by suicide indicate a localized reduction in serotonin transporter (SERT) binding in the ventral prefrontal cortex, which could reflect reduced serotonin input in this area 32, 33 . SERT mRNA is found in the serotonergic neurons of the dorsal raphe nucleus and median raphe nucleus 34 . Some hypothesize that findings in suicide victims of increased tryptophan hydroxylase, reduced SERT mRNA, and reduced number of 5-HT 1A inhibitory autoreceptors, are homeostatic mechanisms that arise secondary to serotonergic deficit 34 .
In support of a role for altered serotonergic function in suicidal behavior in vivo imaging studies report lower C-α -methyl-L-tryptophan trapping in the orbital and ventromedial prefrontal cortex in highlethality suicide attempters, with a negative correlation with suicide intent 35 , and a negative correlation of 5-HT 2A binding with levels of hopelessness, a correlate of suicide and suicide attempt 36 . Oquendo et al., in a PET study, reported found that in response to the administration of the serotonin agonist fenfluramine, depressed high-lethality suicide attempters had lower fluorodeoxyglucose ( 18 F) regional cerebral metabolism of glucose rCMRGlu) in anterior cingulate and superior frontal gyri, compared with depressed low-lethality attempters 26 . In that study, lethality of the most serious lifetime suicide attempt correlated negatively with rCMRGlu in the anterior cingulate, right superior frontal, and right medial frontal gyri suggesting prefrontal cortex hypofunction in high-lethality depressed suicide attempters 26 .
Altered serotonergic function has been associated with certain clinical traits mentioned above. There is substantial literature supporting the role of serotonergic function in aggressive 37 and, to a lesser extent, impulsive 21 behavior. This is consistent with observations that alterations in SERT binding associated with higher risk for suicide appear to be concentrated in the ventral PFC, known to mediate inhibition and restraint 32 
Noradrenergic function
Suicidal and depressed patients have a decreased number of norepinephrine (NE) neurons in the locus ceruleus 43 . Secondary to lower NE levels, greater β-adrenergic cortical receptor binding (downregulation) 44 , and lower α-adrenergic binding (upregulation) 45 have been reported. These changes are suggestive of cortical noradrenergic overactivity that may be attributable to NE depletion from the smaller population of NE neurons found in suicide victims 46 . Moreover, the exaggerated sympathetic responses to stress exhibited by individuals with a history of childhood trauma 44 might further deplete NE function 47 . In cross-sectional studies lower cerebrospinal fluid 3-methoxy-4-hydroxphenylglycol (CSF MHPG), a metabolite of noradrenalin, has been reported in suicide attempters compared to non-attempters in major depression 48 and a sample of criminal offenders 49 , however the majority of crosssectional studies observe no differences (reviewed in 50 ). Prospective studies, potentially better suited to tracking state-dependent noradrenergic stress response, have also produced inconsistent results, with one study reporting that individuals who engaged in repeat suicidal behavior in the year following hospitalization for a suicide attempt were more likely to have above median CSF MHPG levels 51 , and others finding no association with future suicide 23, 52, 53 or suicide attempt 29, 31 . However, a recent prospective study using survival analysis techniques found lower baseline CSF MHPG was associated with increased risk of making a fatal or nonfatal suicide attempt in the 12 months following a major depressive episode 54 .
In studies of the relationship of noradrenergic function and clinical endophenotypes for suicidal behavior, higher NE concentrations are shown to be associated with higher levels of aggression 16 and increased CSF MHPG with greater hostility 55 . Catecholamine depletion resulted in an increase in hopelessness in remitted depressed individuals treated with NRIs 56 , consistent with preclinical studies suggesting NE intervenes in the development of pessimism and hopelessness 57 .
Dopaminergic function
Altered function in the dopaminergic system has been found in depressive disorders and alcohol use disorders 58 , however the role of the dopaminergic system in suicidal behavior is uncertain as the abnormalities observed in some studies may be attributable to depression 16, 59 . Reduced dopamine turnover, indicated by low dihydroxyphenylacetic acid levels, was found in the caudate, putamen, and nucleus accumbens reported in depressed suicides 60 . In another study, the same group found no difference in number or affinity of the dopamine transporters 61 , suggesting it is unlikely that the reduced dopamine turnover initially observed is a result of decreased dopaminergic innervation of those regions. Prospective studies disagree as to whether the dopamine metabo-lite homovanillic acid (HVA) levels in CSF predict suicidal behavior 51, 62-64 . In terms of clinical endophenotypes for suicidal behavior and dopaminergic function, higher CSF HVA levels correlate with increased aggression (for a review see Ryding 37 ) and striatal dopamine D2 receptor binding was correlated with neuroticism scores in a healthy community sample 65 .
Neuroendocrine Endophenotypes

Hypothalamic-PituitaryAdrenal Axis
Postmortem studies of suicides have reported fewer corticotrophin releasing hormone (CRH) receptor binding sites in the frontal cortex 66 and increased CRH concentrations in CSF 67 . Hyperactivity of the HPA axis has been associated with suicidal behavior evidenced by a failure to suppress cortisol secretion following the administration of Dexamethasone (DST). Coryell et al. estimate that DST non-suppressors have a 14-fold higher risk of suicide compared to suppressors 68 . However, DST non-suppression is also associated with posttraumatic stress disorder and depression, and these conditions may mediate the relationship of dexamethasone nonsuppression to suicidal behavior 69 . In non-fatal suicide attempt, DST response is an uncertain indicator of risk, with the majority of prospective studies finding no association between DST nonsuppression and future suicide attempt, although a small number find an association with serious or violent attempts (see 70 for a review). In other indices of HPA axis function there are reports of lower CSF CRH but no difference in plasma CRH or plasma cortisol 71 , higher urinary cortisol in violent attempters 72 , and higher serum cortisol after 5-hydroxytryptophan administration 73 . DST findings provide strong support for a role of abnormal HPA axis mediated physiological stress response in suicide, however the role in non-fatal suicidal behavior requires further elucidation.
HPA axis and neurotransmitters
The HPA axis has complex relationships with the serotonergic, noradrenergic, and dopaminergic systems, further complicating the biological picture. The HPA axis has a bidirectional relationship with the serotonergic system 74 . CRH neurons of the central amygdala are connected to the raphe nuclei 75 , the principal serotonin source to the forebrain. Projections from the raphe nuclei extend to various brain regions that contain CRH and participate in the stress response 75 . HPA hyperactivity observed in suicidal patients may mediate or moderate some of the serotonin abnormalities found in these patients 76 , and corticosteroid modulation of serotonin receptors as a response to stress may have important implications for the pathophysiology of suicide 59, 76 . The HPA axis also has a bidirectional relationship with the NE system. Stress activates not only the HPA axis but also the locus ceruleus (LC) the major source of NE neurons in the brain 77 . This activation leads to increased NE release during stress. LC neurons influence the neuroendocrine stress response system through their broad innervation of the paraventricular nucleus (PVN) projection pathways. Reciprocal interactions connecting cerebral NE and CRH systems may generate a "feed-forward" loop 78 . Severe anxiety in response to stress may be associated with NE overactivity and hyperactivity of the HPA axis, thus contributing to suicide risk 79 . Dopamine modulates the HPA axis response to stress 80, 81 . The DA system is particularly vulnerable to stress and even low intensity stressors, either acute or chronic, can activate DA neurons 82, 83 . However, there is a paucity of data on these effects with respect to suicidal behavior. These interactions suggest multiple pathways through which stress may contribute to the biological anomalies observed in suicidal behavior, both directly through dysfunction of the HPA axis and the noradrenergic system and interactions between these two systems, as well as indirectly through downstream effects on serotonergic and possibly dopaminergic system function.
Neuropsychological Endophenotypes
Deficits in a range of cognitive domains including executive function, attention, language fluency, memory, problem solving and decision-making skills, and impulsiveness have been observed in association with suicidal behavior (reviewed in 14 ). Attentional deficits are frequent in depressed individuals, but significantly more frequent in individuals who have attempted suicide 14 . Although attention may be affected globally in suicide attempters, performance on interference-type tasks can provide more specific information. The Stroop Test and the Continuous Performance Test (CPT) are reliable predictors of attentional deficits 84, 85 . Although Stroop performance does not distinguish attempters and non-attempters 14 , greater effects are observed in the Stroop interference sub-score in depressed suicide attempters compared to depressed non-attempters 86 . Moreover, among depressed attempters, Stroop performance distinguishes high-and low-lethality suicide attempters 86 suggesting that problems with executive control may be associated with more medically serious attempts 14, 86, 87 . Impairments on the Stroop interference task are indicative of difficulty shifting attention from "compelling but inappropriate" stimuli. In a suicidal individuals, such difficulty could predispose to attending to negative emotional states, such as pessimism and self-blame, and lead to action on such states 14 . Impaired attention may also underlie the cognitive rigidity that is a common clinical feature in suicide attempters 14, 88 . In other attention studies, higher rates of CPT omission and commission errors were reported in adolescent suicide attempters compared to non-attempters 89 , however such differences were not observed among adults 14 . Figure 1 indicates two factors at the outset of a putative causal chain leading to suicidal behavior: genetics and early-life adversity. In this section we will review findings that suggest that these two factors impact on both biological and consequently clinical intermediate phenotypes and indicate potential causal pathways leading to suicidal acts.
Genes and early-life environment
Early-life environment
Adverse events in early-life, including sexual or physical abuse, neglect, parental loss, or severe family discord, have been associated with suicidal behavior 90, 91 . Sexual and physical abuse independently contribute to repeated suicide attempts after controlling for a range of other childhood adversities 92 .
One pathway through which early-life adversity contributes to suicidal behavior later in life is through developmental effects on neurobiological systems that have functional consequences in adulthood. Evidence from both animal (see 44 for a review), and human studies demonstrates lasting alterations in HPA axis 93, 94 , and serotonergic 95 and dopaminergic 95, 96 systems, associated with earlylife adversity. These alterations may in turn increase vulnerability for the development of psychiatric disorders 97, 98 , stress sensitivity 96 , and behavioral and personality traits such as impulsivity and aggression 90 later in life, all of which are associated with increased risk for suicidal acts.
Genes and Suicidal Behavior
Twin, adoption, and family studies of suicidal behavior demonstrate a role of genetics in suicidal behavior independent from the presence of axis I or axis II disorders 99, 100 . Population based estimates of the contribution off additive genetic factors are between 30-50% for a broad phenotype of suicidal behavior that includes ideation, plans and attempts (see 101 ), largely independent of the inheritance of psychiatric disorder. Twin studies report that the concordance rate for suicide in twins is higher in monozygotic (24.1%) compared with dizygotic twins (2.8%) 101 . Adoption studies reveal higher suicide rates in the biological parents of adoptees who died by suicide 102, 103 , compared to biological parents of adoptees who did not. Offspring of depressed suicide attempters are more likely to become suicide attempters themselves compared to offspring of depressed non-attempters 100 .
Genetic research in suicidal behavior has included linkage studies, and single nucleotide polymorphism (SNP) association studies. Given the likelihood of a polygenic mode of inheritance 104 , more recent studies adopt novel methodologies involving functional genomics such as using microarray technologies to profile expression of thousands of genes simultaneously (for an overview see 105 ), and genome wide arrays for hundreds of thousands of SNPs 106 . Candidate genes for SNP association studies have been selected largely based on the evidence from neurobiological studies in suicide. To date the serotonergic system has been the most extensively investigated, but other research targets have been the dopaminergic and noradrenergic systems, brain derived neurotrophic factor, and the HPA axis.
Serotonergic system genes
Specific polymorphisms of the 5-HT 2A receptor gene have been associated with suicide attempt in mood disorder patients, including the 102T-1438A and T102C polymorphisms (see Brezo et al. 107 for a review). It is unknown if there is some synergistic effect of the two on suicidal behaviour, or if the latter may just be a marker of the former 108 . However, not all studies show consistent results, and meta-analysis of 25 studies found no association between T102C polymorphism and suicide attempt or suicide 109 .
There is a relatively common polymorphism of the serotonin transporter gene (5-HTTLPR) where the low expressing S allele has been linked to decreased serotonin function in vitro 110 . Meta-analysis that included 12 studies comprising 1599 subjects found a significant association of the 5-HTTLPR low expressing S allele and suicidal behavior 109 . However, studies of the 5-HTTLPR genotype and serotonergic function in suicide have been few. In studies examining 5-HT-TLPR and serotonin transporter density in postmortem brains individuals who died by suicide one reported an association 111 and four did not 33, [112] [113] [114] . A recent SPECT study in a small sample of male suicide attempters found that the S allele was associated with lower transporter availability in suicide attempters but not in controls 115 . Other imaging studies have examined brain function more generally, with respect to 5-HTTLPR genotype (see Brown & Hariri 116 for a review). In healthy adults, multiple studies report that individuals with the lower expressing SS genotype show increased amygdala activity when exposed to angry or fearful faces, negative words, or aversive pictures [117] [118] [119] [120] [121] [122] . The amygdala has a central in role in encoding of emotional memories, emotional regulation and responses to stress 123 , and is densely innervated by serotonergic neurons and 5-HT receptors are abundant [124] [125] [126] .
Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the synthesis of serotonin. Two variants have been described: TPH1 and TPH2 127 . Some, but not all, studies reported TPH1 SNP associations with suicidal behavior 128 , and aggression 129 (see Baldessarini & Hennen 130 for a review). For TPH2, haplotype studies in psychiatric samples report associations with suicide 131 and suicide attempt 132, 133 , and single SNP studies report associations between TPH2 genotype and suicidal behavior in Chinese 134 and German Caucasian 135 psychiatric samples, but many others fail to observe any associations 107 . Potential endophenotypes for the expression of the TPH2 gene are suggested in studies that find genotype association with decreased executive function 136, 137 and attention 136 , altered amygdala response 138 and, in an fMRI, study altered functioning in prefrontal and parietal brain regions associated with working memory 139 .
Several studies have shown an association between alterations in the monoamine oxidase A (MAOA) gene and aggression 140, 141 , an element in the diathesis for suicidal behavior. Additionally, the MAOA-uVNTR polymorphism has been associated higher impulsivity in males 142 . Because the gene for MAOA is sex linked, it is hypothesized that the higher rate of suicides among males could be due to greater impulsivity and aggression, secondary to specific MAOA polymorphisms 143 . An fMRI study found that the low expressing alleles of the u-VNTR were associated with increased risk of violent behavior and with alterations in the corticolimbic circuitry involved in affect regulation, emotional memory and impulsivity 144 . In two other fMRI studies MAOA genotype affected performance on response tasks indicative of impulsivity 145, 146 .
Other genes
The catechol-O-methyltransferase (COMT) enzyme is a major enzyme in NE activation. COMT activity is affected by a single nucleotide polymorphism at codon 158 (COMT-Val/Met 158) where the allele encoding a valine residue (Val allele) is associated with higher catalytic activity compared with the allele encoding a methionine residue (Met allele) 147 . Some authors suggest that this polymorphism might modify not the susceptibility to, but the clinical course of suicidal behavior making it more violent and lethal 148 . Recent meta-analysis of 519 cases and 933 controls from 6 studies found suggestive evidence of an association between COMT-Val/Met 158 polymorphism and suicidal behavior, perhaps related to the lethality of suicide attempt 149 . Supporting this are reports of association between the low functioning Met allele and impulsive aggression in schizophrenia 150-152 and violent suicide attempts 153 .
The noradrenergic and dopaminergic systems, HPA axis, and neurotrophic factor BDNF have also been examined for candidate genes, with no consistent associations yet identified (for an overview see Rujescu et al. 154 ).
Genes and Early-Life environment
The disparate findings in genetic association studies may in part be attributable to differences in environmental characteristics of study samples. Pre-clinical studies demonstrate that early-life adversity interacts with genotype and the resultant biological and behavioral alterations endure into adulthood 155, 156 . In humans, there have been multiple studies of early-life environment/ 5-HTTLPR interaction and vulnerability for psychiatric disorder, with most, but not all, reporting an effect (see Uher 157 for a review). With respect to suicidal behavior, Caspi et al found that among individuals who had experienced childhood maltreatment, only those with the low expressing S 5-HTTLPR allele were at risk for suicidal ideation and suicide attempt 158 . Other studies of the 5-HTTLPR report childhood adversity-genotype interactions and suicidal behavior in mixed diagnosis inpatients 159 and among abstinent African American substance dependent patients 160 . Adverse childrearing, in combination with a lower expressing variant of the MAO A gene was also found to contribute, in males only, to the development of antisocial behavior and more impulsivity, both of which may contribute to suicidal behavior 142, 161 .
It is likely that such effects occur with genes related to the other neurobiological systems involved in suicidal behavior, for example, a recent study found an interaction effect between CRH Receptor 1 haplotype gene and early-life stress on the severity of depression 162 . That study did not examine suicide related outcomes, however it is suggestive of another potential pathway whereby genes and environment contribute to vulnerability for suicidal behavior. More recently, preclinical studies have begun to investigate epigenetic mechanisms such as methylation as a pathway through which environment interacts with genetics to influence biological development and behavioral outcomes 163 .
Therapeutic Implications
Suicide prevention is possible as up to 83% of individuals who die by suicide have had contact with a primary care physician in the year prior to their death 164 . However, despite the development of theoretical models, it is not yet possible to reliably predict suicide and suicide attempt. However, the approach described here may allow better identification of high-risk populations. Studies of predictive utility of the two most extensively investigated biological alterations in suicidal behavior, CSF 5-HIAA and DST nonsuppression, have resulted in low positive predictive values for suicide, mainly due to lack of specificity but also because of the low base rates of suicide. Improvement in predicting suicide risk may involve combining several risk factors. Both biological and clinical prospective studies suggest that combining information obtained from two markers (i.e. CSF 5HIAA and DST results and aggression/impulsivity and pessimism) were better predictors than either marker alone 22, 27 . Further studies that utilize a combination of biological and clinical markers may prove even more successful.
Summary and Conclusions
An individual's risk of suicide and/or suicide attempt stems from the interaction between the diathesis, or predisposition, for suicidal behavior, and the occurrence of triggers 17 . The diathesis may comprise traits in the clinical, neurobiological, neurocognitive, genetic, behavioral, and personality domains. Via different pathways, these will affect the way in which an individual responds to stressful life events that may act as triggers for a suicidal act. Due to the complexity and multi-determined nature of suicidal behavior, a model that can integrate a number of risk factors identified as endophenotypes for suicidal behavior may better facilitate identification of high risk populations and thereby identify targets for intervention. 
